Bristol Myers Squibb Announces Dividend

NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of fifty-four cents ($0.54) per share on the $.10 par value common stock of the company. The dividend is payable on May 2, 2022 to stockholders of record at the close of business on April 1, 2022.

In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable June 1, 2022, to stockholders of record at the close of business on May 10, 2022.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20220301006211/en/

Media:
[email protected]

Investors:
[email protected]

Source: Bristol Myers Squibb

You May Also Be Interested In

• Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 2026
• Local Business Manager Launches a Complete Suite for Local Businesses to Dominate Their Market
• HMPI Highlights the Growing Role of Corporate Services as Business Needs Evolve in Timor-Leste